Epithelioid GBMs Show a High Percentage of BRAF V600E Mutation
暂无分享,去创建一个
[1] Lauren E Haydu,et al. Distinguishing Clinicopathologic Features of Patients with V600E and V600K BRAF-Mutant Metastatic Melanoma , 2012, Clinical Cancer Research.
[2] Yu Shyr,et al. Survival in BRAF V600-mutant advanced melanoma treated with vemurafenib. , 2012, The New England journal of medicine.
[3] K. Drummond,et al. Malignant potential of pleomorphic xanthoastrocytoma , 2012, Journal of Clinical Neuroscience.
[4] Barbara S. Paugh,et al. Targeted Therapy for BRAFV600E Malignant Astrocytoma , 2011, Clinical Cancer Research.
[5] A. Hauschild,et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. , 2011, The New England journal of medicine.
[6] A. Iafrate,et al. BRAF V600E Mutations Are Common in Pleomorphic Xanthoastrocytoma: Diagnostic and Therapeutic Implications , 2011, PloS one.
[7] Kirsten Schmieder,et al. Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma , 2011, Acta Neuropathologica.
[8] J. Hamada,et al. Epithelioid glioblastoma changed to typical glioblastoma: the methylation status of MGMT promoter and 5-ALA fluorescence , 2011, Brain Tumor Pathology.
[9] J. Biegel,et al. Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas. , 2010, Neuro-oncology.
[10] K. Newell,et al. Epithelioid Versus Rhabdoid Glioblastomas Are Distinguished by Monosomy 22 and Immunohistochemical Expression of INI-1 but not Claudin 6 , 2010, The American journal of surgical pathology.
[11] H. Zentgraf,et al. Characterization of R132H Mutation‐specific IDH1 Antibody Binding in Brain Tumors , 2010, Brain pathology.
[12] Y. Fujii,et al. Intraventricular pleomorphic xanthoastrocytoma with anaplastic features , 2009, Neuropathology : official journal of the Japanese Society of Neuropathology.
[13] David T. W. Jones,et al. IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas. , 2009, Neuro-oncology.
[14] H. Horiguchi,et al. Primary anaplastic pleomorphic xanthoastrocytoma with widespread neuroaxis dissemination at diagnosis––a pediatric case report and review of the literature , 2009, Journal of Neuro-Oncology.
[15] N. Balak,et al. Anaplastic pleomorphic xanthoastrocytoma , 2009, Child's Nervous System.
[16] G. Fuller,et al. Multifocal epithelioid glioblastoma mimicking cerebral metastasis: case report. , 2009, Neurocirugia.
[17] B. Scheithauer,et al. Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma , 2008, Cancer.
[18] Andrey Korshunov,et al. Analysis of the IDH1 codon 132 mutation in brain tumors , 2008, Acta Neuropathologica.
[19] Tchoyoson C. C. Lim,et al. Pleomorphic xanthoastrocytoma in elderly patients may portend a poor prognosis , 2008, Journal of Clinical Neuroscience.
[20] S. Kannuki,et al. Pleomorphic xanthoastrocytoma: a comparative pathological study between conventional and anaplastic types , 2007, Histopathology.
[21] A. Feletti,et al. Malignant progression in pleomorphic xanthoastrocytoma: Personal experience and review of the literature , 2007, Journal of the Neurological Sciences.
[22] D. Louis. WHO classification of tumours of the central nervous system , 2007 .
[23] M. Kudo,et al. Epithelioid glioblastoma: a case report , 2005, Brain Tumor Pathology.
[24] A. Sav,et al. Anaplastic Pleomorphic Xanthoastrocytomas , 2004, Pediatric Neurosurgery.
[25] F. Cheung,et al. Pleomorphic xanthoastrocytoma: report of two cases and review of the prognostic factors , 2004, Journal of Clinical Neuroscience.
[26] A. Korshunov,et al. Pleomorphic Xanthoastrocytomas: Immunohistochemistry, Grading and Clinico-pathologic Correlations. An Analysis of 34 Cases From a Single Institute , 2001, Journal of Neuro-Oncology.
[27] A. Sav,et al. Anaplastic pleomorphic xanthoastrocytomas. Review of the literature with reference to malignancy potential. , 2004, Pediatric neurosurgery.
[28] L. J. Rubinstein,et al. Histopathological features of recurrent pleomorphic xanthoastrocytomas: further corroboration of the glial nature of this neoplasm , 2004, Acta Neuropathologica.
[29] S. Powell,et al. Giant cell glioblastoma and pleomorphic xanthoastrocytoma show different immunohistochemical profiles for neuronal antigens and p53 but share reactivity for class III beta-tubulin. , 2003, Archives of pathology & laboratory medicine.
[30] G. Reifenberger,et al. Genetic Alterations Commonly Found in Diffusely Infiltrating Cerebral Gliomas Are Rare or Absent in Pleomorphic Xanthoastrocytomas , 2002, Journal of neuropathology and experimental neurology.
[31] M. Shigemori,et al. Clinicopathological study of pleomorphic xanthoastrocytoma: Correlation between histological features and prognosis , 2000, Pathology international.
[32] L. Bridges,et al. Malignant transformation in pleomorphic xanthoastrocytoma--a report of two cases. , 1999, British journal of neurosurgery.
[33] D. Brat,et al. Pleomorphic xanthoastrocytoma , 1999, Cancer.
[34] G. Fuller,et al. EPITHELIOID GLIOBLASTOMA: A DISTINCT CLINICOPATHOLOGIC ENTITY , 1998 .
[35] Y. Yonekawa,et al. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.
[36] P. Pahapill,et al. Pleomorphic xanthoastrocytoma: case report and analysis of the literature concerning the efficacy of resection and the significance of necrosis. , 1996, Neurosurgery.
[37] V. Jay,et al. Increased mitotic activity as a negative prognostic indicator in pleomorphic xanthoastrocytoma. Case report. , 1993, Journal of neurosurgery.
[38] M. Yoshino,et al. Pleomorphic xanthoastrocytoma. , 1992, AJNR. American journal of neuroradiology.
[39] J. Kros,et al. The pleomorphic xanthoastrocytoma and its differential diagnosis: a study of five cases. , 1991, Human pathology.
[40] M. Rosenblum,et al. The Lipid‐Rich Epithelioid Glioblastorna , 1991, The American journal of surgical pathology.
[41] J. Mackenzie. PLEOMORPHIC XANTHOASTROCYTOMA IN A 62‐YEAR‐OLD MALE , 1987, Neuropathology and applied neurobiology.
[42] R. Barnard,et al. The classification of tumours of the central nervous system. , 1982, Neuropathology and applied neurobiology.
[43] L. Eng,et al. Pleomorphic xanthoastrocytoma: A distinctive meningocerebral glioma of young subjects with relatively favorable prognosis A study of 12 cases , 1979, Cancer.